BRAF and hereditary disease: Since GD is not a genetic disorder that can be easily replicated using knockout cells or mice, we established a model of drug-induced GD using B-RAF inhibitors that have been robustly linked in clinical studies to inducing specific GD pathology in patients (15, 16).